The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Noonberg Sarah B. since 2021.
This trader's CIK number is 1706301.
At the time of last reporting, Noonberg Sarah B. was the Chief Medical Officer of Metagenomi, Inc.. (stock ticker symbol MGX).
Also see all insider trading activities at Metagenomi, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | PTGX | 0 | $0 | 8,400 | $213,764 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | MGX | 0 | $0 | 5,239 | $9,168 | 0 | $0 |
1. Protagonist Therapeutics, Inc (PTGX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-11 | PTGX | Sale | 3,700 | 25.09 | 92,833 |
| 2021-02-10 | PTGX | Sale | 4,700 | 25.73 | 120,931 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-06 | MGX | Sale | 5,239 | 1.75 | 9,168 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Noonberg Sarah B. (Chief Medical Officer of Metagenomi, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.